Search

everythinglearnresearchcommunity

for

Search:↓

Human dermal fibroblasts are the main cells targeted by a virus that can cause a deadly skin cancer, and a certain inhibitor can effectively block this infection.

Skin bacteria, specifically Staphylococcus aureus, help in wound healing and hair growth by using IL-1β signaling. Using antibiotics on skin wounds can slow down this natural healing process.

Skin bacteria, specifically Streptococcus and Staphylococcus, help in hair regrowth after skin injury and speed up wound healing.

A woman's hair loss worsened after starting hepatitis C treatment due to immune changes in her hair follicles.

Blocking CCR5 can prevent and improve hair loss in alopecia areata.

New treatments for Hepatitis C show promise but need more research to confirm their safety and effectiveness for clinical use.

Injecting anti-herpes antibodies locally can prevent skin lesions and sweating problems caused by herpes simplex virus in mice.

Hepatitis B virus exposure may be linked to increased risk of alopecia areata.

Interferon α‐2b can temporarily reduce hepatitis C virus and normalize liver enzyme levels.

High-dose interferon is effective for chronic hepatitis C but often causes flu-like symptoms.

Avicennia marina shows potential to treat Hepatitis C by targeting key proteins.

Blocking IL-17 can reduce joint inflammation in Ross River Virus infections.

Peginterferon alpha-2a effectively treats acute hepatitis C in hemodialysed patients, despite some side effects.

A man with HIV developed skin and hair issues after starting HIV treatment, which improved with topical treatment.

Betulinic acid can help treat hepatitis C by stopping virus replication.

The research developed methods to test drugs that could protect and restore hair follicle protection in a hair loss condition.

Blocking the CCR5 receptor may be a new way to treat hair loss from alopecia areata.

A patient developed hair loss after hepatitis C treatment with sofosbuvir and ribavirin.

Cepharanthine could be a strong antiviral against COVID-19.

Simvastatin helps hair regrowth in autoimmune alopecia by directly affecting T cells.

Some patients on immunosuppressants had a weaker immune response to the Sinovac-CoronaVac COVID-19 vaccine.

HHV-6 reactivation may be linked to psychiatric disorders and can improve with antiviral treatment.

An HIV patient's complete hair loss was reversed after switching from lopinavir/ritonavir to nelfinavir.

Viral reactivation is rare at the time of DRESS diagnosis in the U.S.

Vogt-Koyanagi-Harada disease can develop during interferon therapy for chronic hepatitis C.

Manage side effects of hepatitis C treatment with dose changes and medications, which may improve patient adherence and treatment success.

ART for HIV/AIDS can cause side effects but is crucial for managing the infection.

Bromhexine and spironolactone together reduced COVID-19 symptoms and hospitalization time without side effects.

Hair antiretroviral concentration is affected by hair type, segment position, housing, drug use, sexual behavior, kidney function, and genetics.